Back
Day Range
$19.23
$20.08
52-Week Range
$17.03
$31.26
Volume
394,739
50D / 200D Avg
$24.98
/
$25.55
Prev Close
$19.50
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 9.0 | 0.4 |
| P/B | 1.1 | 2.9 |
| ROE % | 12.9 | 3.8 |
| Net Margin % | 13.6 | 3.9 |
| Rev Growth 5Y % | 13.2 | 10.0 |
| D/E | 0.8 | 0.2 |
Key Takeaways
Revenue grew 13.24% annually over 5 years — strong growth
Earnings declined -38.51% over the past year
ROE of 12.90% — decent returns on equity
Generating 121.23M in free cash flow
P/E of 9.01 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 14.89%
Growth
Revenue Growth (5Y)
13.24%
Revenue (1Y)-1.65%
Earnings (1Y)-38.51%
FCF Growth (3Y)-8.67%
Quality
Return on Equity
12.90%
ROIC7.29%
Net Margin13.63%
Op. Margin19.50%
Safety
Debt / Equity
0.83
Current Ratio4.02
Interest Coverage5.51
Valuation
P/E Ratio
9.01
P/B Ratio1.12
EV/EBITDA9.75
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.65% | Revenue Growth (3Y) | 5.70% |
| Earnings Growth (1Y) | -38.51% | Earnings Growth (3Y) | -15.55% |
| Revenue Growth (5Y) | 13.24% | Earnings Growth (5Y) | 12.10% |
| Profitability | |||
| Revenue (TTM) | 719.89M | Net Income (TTM) | 98.09M |
| ROE | 12.90% | ROA | 6.02% |
| Gross Margin | 49.46% | Operating Margin | 19.50% |
| Net Margin | 13.63% | Free Cash Flow (TTM) | 121.23M |
| ROIC | 7.29% | FCF Growth (3Y) | -8.67% |
| Safety | |||
| Debt / Equity | 0.83 | Current Ratio | 4.02 |
| Interest Coverage | 5.51 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 9.01 | P/B Ratio | 1.12 |
| P/S Ratio | 1.23 | PEG Ratio | -0.35 |
| EV/EBITDA | 9.75 | Dividend Yield | 0.00% |
| Market Cap | 883.66M | Enterprise Value | 1.37B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 719.89M | 731.97M | 644.40M | 498.99M | 437.77M |
| Net Income | 98.09M | 159.52M | 137.55M | 91.39M | 62.12M |
| EPS (Diluted) | 2.03 | 3.06 | 2.60 | 1.74 | 1.25 |
| Gross Profit | 356.06M | 373.86M | 351.12M | 248.86M | 199.74M |
| Operating Income | 140.40M | 205.42M | 196.99M | 107.50M | 69.89M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.63B | 1.58B | 1.51B | 741.99M | 671.53M |
| Total Liabilities | 840.49M | 845.17M | 873.49M | 213.33M | 226.01M |
| Shareholders' Equity | 788.81M | 732.30M | 639.42M | 528.66M | 445.52M |
| Total Debt | 656.00M | 650.55M | 623.64M | 102.58M | 104.66M |
| Cash & Equivalents | 170.18M | 151.61M | 144.30M | 156.10M | 126.35M |
| Current Assets | 636.02M | 534.07M | 489.60M | 378.32M | 318.12M |
| Current Liabilities | 158.16M | 173.76M | 225.41M | 94.86M | 103.81M |